# Fortress Biotech, Inc.: Form 8-K, filed Mar 28, 2022

- Company: [Fortress Biotech, Inc.](/companies/fbio.md) (CIK 1429260)
- Form: 8-K
- Filed: 2022-03-28
- Accepted by EDGAR: Mar 28, 2022, 08:16 ET
- Period: 2022-03-28
- Accession: 0001104659-22-038430
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1429260/000110465922038430/tm2210550d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1429260/000110465922038430/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1429260/000110465922038430/tm2210550d1_8k.htm

Filed Mar 28, 2022.
Source: SEC EDGAR, the filing index for accession 0001104659-22-038430. Last ingested by Listed: Nov 14, 2026, 11:27 ET. No prices; not investment advice.
